Inhibitors of leukocyte-endothelial cell interactions as anti-inflammatory therapeutics - update
- 1 August 1994
- journal article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 3 (8) , 861-869
- https://doi.org/10.1517/13543784.3.8.861
Abstract
(1994). Inhibitors of leukocyte-endothelial cell interactions as anti-inflammatory therapeutics - update. Expert Opinion on Investigational Drugs: Vol. 3, No. 8, pp. 861-869. doi: 10.1517/13543784.3.8.861Keywords
This publication has 31 references indexed in Scilit:
- Antiinflammatory Effects in Experimental Meningitis of Prokaryotic Peptides that Mimic SelectinsThe Journal of Infectious Diseases, 1993
- Peptides from multiple regions of the lectin domain of P‐selectin inhibiting neutrophil adhesionInternational Journal of Peptide and Protein Research, 1993
- o-Phenylphenols: potent and orally active leukotriene B4 receptor antagonistsJournal of Medicinal Chemistry, 1993
- Biphenylyl-substituted xanthones: highly potent leukotriene B4 receptor antagonistsJournal of Medicinal Chemistry, 1993
- Circulating adhesion molecules in diseaseImmunology Today, 1993
- Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear.Journal of Clinical Investigation, 1993
- Prokaryotic peptides that block leukocyte adherence to selectins.The Journal of Experimental Medicine, 1993
- Biotech Gets a Grip on Cell AdhesionScience, 1993
- Additive effects of a bradykinin antagonist, NPC 17761, and a leumedin, NPC 15669, on survival in animal models of sepsisInflammation Research, 1993
- Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes.The Journal of Experimental Medicine, 1992